Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-30
2010-10-12
Wilson, James O (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C549S398000
Reexamination Certificate
active
07812183
ABSTRACT:
The present invention is directed to novel benzopyran derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders related to potassium channel.
REFERENCES:
patent: 4210591 (1980-07-01), Burri
patent: 4631282 (1986-12-01), Cassidy
patent: 4812459 (1989-03-01), Evans et al.
patent: 4931454 (1990-06-01), Baumgarth et al.
patent: 4971982 (1990-11-01), Attwood et al.
patent: 4983612 (1991-01-01), Quagliato et al.
patent: 4987138 (1991-01-01), Cassidy et al.
patent: 5028711 (1991-07-01), Stenzel et al.
patent: 5096914 (1992-03-01), Stenzel et al.
patent: 5112839 (1992-05-01), Gericke et al.
patent: 5112972 (1992-05-01), Gericke et al.
patent: 5118694 (1992-06-01), Attwood et al.
patent: 5171857 (1992-12-01), Quagliato
patent: 5206252 (1993-04-01), Butera et al.
patent: 5225566 (1993-07-01), Butera et al.
patent: 5236935 (1993-08-01), Yoo et al.
patent: 5238937 (1993-08-01), Gericke et al.
patent: 5254555 (1993-10-01), Stemp et al.
patent: 5254557 (1993-10-01), Buckle et al.
patent: 5254578 (1993-10-01), Hashimoto et al.
patent: 5284838 (1994-02-01), Garcia et al.
patent: 5310932 (1994-05-01), Atwal et al.
patent: 5387587 (1995-02-01), Hausler et al.
patent: 5470872 (1995-11-01), Buckle et al.
patent: 6153627 (2000-11-01), Hausler et al.
patent: 6268388 (2001-07-01), Rajfer
patent: 2007/0049556 (2007-03-01), Zhang et al.
patent: 0172352 (1986-02-01), None
patent: 0205292 (1986-12-01), None
patent: 0214818 (1987-03-01), None
patent: 0273262 (1988-07-01), None
patent: 0298452 (1989-01-01), None
patent: 0301713 (1989-02-01), None
patent: 0308792 (1989-03-01), None
patent: 0350805 (1990-01-01), None
patent: 0363883 (1990-04-01), None
patent: 0400430 (1990-12-01), None
patent: 0406656 (1991-01-01), None
patent: 0413438 (1991-02-01), None
patent: 0488301 (1992-06-01), None
patent: 0489327 (1992-06-01), None
patent: 0655448 (1995-05-01), None
patent: 2670780 (1992-06-01), None
patent: 2242628 (1991-10-01), None
patent: WO 93/23393 (1993-11-01), None
patent: WO 2005/033073 (2005-04-01), None
patent: WO2007/027780 (2007-08-01), None
Annex to Form PCT/ISA/206, Communication Relating to the Results of the Partial International Search for International Appln. No. PCT/US2006/033871.
Aguilar-Bryan et al.: “Toward Understanding the Assembly and Structure of KatpChannels”; Physiological Reviews vol. 78(1) Jan. 1998; 227-245.
Ashwood, V.A. et al.: “Synthesis and Antihypertensive Activity of Pyran Oxygen and Amide Nitrogen Replacement Analogues of the Potassium Channel Activator Cromakalim”, Journal of Medicinal Chemistry, American Chemical Society, Washington, U.S., vol. 34, No. 11, Nov. 1991, pp. 3261-3267, XP002034759.
Ashwood, V.A. et al.: Synthesis and Antihypertensive Activity of 4-(Cyclic Amido)-2H-1-Benzopyrans:, Journal of Medicinal Chemistry, American Chemical Society. Washington, US, vol. 29, 1986, pp. 2194-2201, XP008050667.
Atwal, K.S. et al.: “Cardioselective Anti-Ischemic ATP-Sensitive Potassium Channel Openers. 3. Structure-Activity Studies of Benzopyranyl Cyanoguanidines”, Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 38, No. 17, 1995, pp. 3236-3245, XP009030005.
Attwood, M.R. et al.: Tetrahedron Letters, Elsevier, Amsterdam, NL, vol. 32, No. 6, 1991, pp. 811-814, XP002082330.
Bergmann, R. et al.: Synthesis and antihypertensive activity of 4-(1,2-dihydro-2-oxo-1-pyridyl)-2H-1-benzoyrans and related compounds, new potassium channel activators:, Journal of Medicinal Chemistry, Feb. 1990, vol. 33, No. 2, pp. 492-504, XP002418874.
Bergmann, R. et al.: “4-Heterocyclyloxy02H-1-Benzopyran Potassium Channel Activators”, Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 33, No. 10, Oct. 1, 1990, pp. 2759-2767, XP000566902.
Buckle, D.R. et al.: “Relaxant Activity of 4-amido-3, 4-dihyro-2H-1-benzopyran-3-ols and 4-amido-2H-1-benzopyrans on guinea pig isolated trachealis”, Journal of Medicinal Chemistry, Nov. 1990, vol. 33(11) pp. 3028-3034, XP002418873.
Burrell, G. et al.: “Variation in the aromatic ring of cromakalim: antihypertensive activity of pyranopyridines and 6-alkyl-2H-1-benzopyrans”, Journal of Medicinal Chemistry, Nov. 1990, vol. 33, No. 11, pp. 3023-3027, XP002418872.
Edwards, G. et al.: “Structure-Activity Relationships of K+ Channel Openers”.Trends in Pharmacological Sciences, Elsevier, Haywarth, GB, vol. 11, No. 10, Oct. 1990, pp. 417-422, XP002034758.
Gabbutt, et al.: “Reactions of Some 2H-Chromenes and 2H-Thiochromenes with Triazolinediones”, Tetrahedron, Elsevier Science Publishers, Amsterdam, NL, vol. 51, No. 48, Nov. 1995, pp. 13277-13290, XP005249958.
Kabbe, H.J. et al.: “Synthesen und Umsetzungen von-4-Chromanonen”, Angewandte Chemie, VCH Verlagsgesellschaft, Weinheim, DE, vol. 94, 1982, pp. 254-262, XP002418875.
Mannhold, R. et al.: “6-Substituted benzopyrans as potassium channel activators: synthesis, vasodilator properties, and multivariate analysis”, Journal Of Medicinal Chemistry, Mar. 25, 1999, vol. 42, No. 6, pp. 981-991, XP002418870.
Robertson, D.W. et al.: “Potassium Channel Modulators: Scientific Applications and Therapeutic Promise”, Journal of Medicinal Chemistry, American Chemical Society, Washington, U.S., vol. 33, No. 6, Jun. 1990, pp. 1529-1541, XP002034757.
Salamon, E. et al.: “6-Sulfonylchromenes as highly potent K(ATP)-channel openers”, Journal of Medicinal Chemistry, Feb. 28, 2002, vol. 45, No. 5, pp. 1086-1097, XP002418871.
Vuligonda, V. et al.: “A new class of potent RAR antagonists: dihydroanthracenyl, benzochromenyl and benzothiochromenyl retinoids” Bioorganic & Medicinal Chemistry Letters, Oxford, GB, vol. 9, No. 5, Mar. 8, 1999, pp. 743-748, XP004157605.
Wein, A.J., MD: “Overactive Bladder: Defining the Disease”; the American J. of Managed Care, vol. 6(11) Jul. 2000, S559-S564.
PCT International Search Report, PCT/US2006/033871, Apr. 18, 2007.
Lee, Sunkyung, et al. “4-[(N-imidazol-2-ylmethyl)anilino]pyranopyridine Analogs as Novel Anti-Angiogenic Agents”. Bulletin of the Korean Chemical Society, 26(4), Apr. 20, 2005, pp. 619-628, XP002429858.
Santhosh, K.C. et al: “Synthesis of Pterocarpans by Means of a Disfavored 5-endo-trig Radical Cyclization Reaction”. European Journal of Organic Chemistry, Wiley-VCH Verlag, Weinheim, DE 2001, pp. 3461-3466, XP002429857.
Sato, H. et al. “Vasorelaxant Activity of 2-fluoroalky1-6-nitro-2H-1-benzopyran-4-Carb Othioamide and -carboxamide K<+> Channel Openers”. Bioorganiz & Medicinal Chemistry Letters, Oxford, GB, vol. 5, No. 3, Feb. 2, 1995, pp. 233-236, XP004819353.
Taka, et al. “6-Substituted 2,2-Bis(fluoromethyl)-Benzopyran-4-Carboxamide K+ Channel Openers”. Bioorganic & Medicinal Chemistry, Elsevier Science Ltd, GB, vol. 8, No. 6, 2000, pp. 1393-1405, XP002212443.
Tawata, S. et al.: “Syntheses and Biological Activities of Dihydro-5,6-Dehydrokawain Derivatives”. Bioscience Biotechnology Biochemistry, Japan Society for Bioscience, Biotechnology and Agrochem, Tokyo, JP, vol. 60, No. 10, Oct. 1996, XP001078728.
Yoshino, K. et al. “Organic Phosphorus Compounds.5.(4-Benzothiazol-2-ylbenzyl)Amidophosphonate as Potent Calcium Antagonistic Vasodilators”. Journal of Medicinal Chemistry, Aug. 1990, vol. 33, No. 8, pp. 2192-2196, XP002429859.
Li Xiaojie
Sui Zhihua
Zhang Xuqing
Janssen Pharmaceutica NV
Kentoffio Joseph S.
McKown Jeremy K.
Murray Jeffrey H
Wilson James O
LandOfFree
Benzopyran derivatives as potassium channel openers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzopyran derivatives as potassium channel openers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzopyran derivatives as potassium channel openers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4238474